FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

789066008: Relebactam (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3786598017 Relebactam (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3786599013 Relebactam en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Relebactam (substance) Is a Enzyme inhibitor false Inferred relationship Some
Relebactam (substance) Is a Antibacterial true Inferred relationship Some
Relebactam (substance) Is a Substance with beta-lactamase inhibitor mechanism of action true Inferred relationship Some
Relebactam (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Relebactam (substance) Is a Azabicyclo compound (substance) true Inferred relationship Some
Relebactam (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta-lactamase inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing cilastatin and imipenem and relebactam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relebactam (substance) Inferred relationship Some 2
Product containing only cilastatin and imipenem and relebactam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relebactam (substance) Inferred relationship Some 2
Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relebactam (substance) Inferred relationship Some 2
Cilastatin and imipenem and relebactam only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relebactam (substance) Inferred relationship Some 2
Relebactam monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Relebactam (substance) Inferred relationship Some
Relebactam anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Relebactam (substance) Inferred relationship Some
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Relebactam (substance) Inferred relationship Some 2
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Relebactam (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start